Results 341 to 350 of about 986,227 (410)
Some of the next articles are maybe not open access.
Annual Review of Microbiology, 1974
PROKARYOTES . Cellular Pools of cAMP and Release of cAMP. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 362 Adenyl Cyclase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 363 cAMP Phosphodiesterase. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
openaire +3 more sources
PROKARYOTES . Cellular Pools of cAMP and Release of cAMP. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 362 Adenyl Cyclase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 363 cAMP Phosphodiesterase. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
openaire +3 more sources
Interdomain interaction of cyclic AMP receptor protein in the absence of cyclic AMP
Journal of Biochemistry, 2007Interdomain interaction of apo-cyclic AMP receptor protein (apo-CRP) was qualified using its isolated domains. The cAMP-binding domain was prepared by a limited proteolysis, while the DNA-binding domain was constructed as a recombinant protein. Three different regions making interdomain contacts in apo-CRP were identified by a sequence-specific ...
Hyun-Suk Ko+4 more
openaire +3 more sources
The measurement of cyclic GMP and cyclic AMP phosphodiesterases
Analytical Biochemistry, 1979Abstract Methods are described for measuring phosphodiesterases for cGMP and cAMP in the range of activity yielding 10 −12 to 10 −8 mol of product. The 5′-GMP formed is measured by conversion to GDP with guanylate kinase. Amounts of GDP greater than 10 −10 mol are measured directly with an enzyme system which results in stoichiometric oxidation of
Joyce G. Carter+2 more
openaire +3 more sources
Annual Review of Pharmacology, 1974
A chapter on "Cyclic AMP and Drug Action" has already been published in Annual Review of Pharmacology (1). In spite of its restrictive title, this paper covered most of the knowledge about the biochemical and biological effects of cAMP that was available in 1969.
openaire +2 more sources
A chapter on "Cyclic AMP and Drug Action" has already been published in Annual Review of Pharmacology (1). In spite of its restrictive title, this paper covered most of the knowledge about the biochemical and biological effects of cAMP that was available in 1969.
openaire +2 more sources
The role of cyclic AMP and cyclic GMP in byssinosis
American Industrial Hygiene Association Journal, 1979The lungs of female guinea pigs, either untreated or previously sensitized with aqueous extracts of cotton dust (AECD) were perfused via the pulmonary artery with 0, 10-6, 10-5 or 10-4 g/mL of lyophilized AECD in Tyrodes solution. Pressure changes in the pulmonary artery were monitored during this period.
Gerald A. Greenblatt, M H Elissalde
openaire +3 more sources
Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA.
Science, 1988Cyclic AMP (cAMP) is an intracellular second messenger that activates transcription of many cellular genes. A palindromic consensus DNA sequence, TGACGTCA, functions as a cAMP-responsive transcriptional enhancer (CRE). The CRE binds a cellular protein of
J. Hoeffler+4 more
semanticscholar +1 more source
Cyclic AMP in Hypersensitivity Reactions
Allergy, 1979Phytohemagglutinin (PHA) was capable of inducing non‐cytotoxic histamine release from human leucocytes. In the presence of deuterium oxide (D2O), PHA caused significantly greater histamine release. Dibutyryl cyclic AMP id‐cAMP) could enhance the histamine release in the presence of D2O although it was an inhibitor of the release if used alone. However,
F. Anfosso+3 more
openaire +3 more sources
1981
Publisher Summary This chapter discusses the nephrogenous cyclic AMP. The total amount of cyclic AMP (cAMP) excreted is the sum of that derived from two sources, that is, the filtered load of the nucleotide and nephrogenous cAMP. On an average, each component accounts for approximately 50% of the total quantity of cAMP excreted by normal individuals.
openaire +3 more sources
Publisher Summary This chapter discusses the nephrogenous cyclic AMP. The total amount of cyclic AMP (cAMP) excreted is the sum of that derived from two sources, that is, the filtered load of the nucleotide and nephrogenous cAMP. On an average, each component accounts for approximately 50% of the total quantity of cAMP excreted by normal individuals.
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1974
To the Editor.— Dr. Auerbach reports (227:326, 1974) on the topical use of dibutylated cyclic adenosine monophosphate (cyclic AMP) in patients with psoriasis, the rationale being to elevate the reduced levels of skin cyclic AMP in these people. He observed either no improvement or worsening of lesions and suggests several possible reasons for lack of ...
openaire +3 more sources
To the Editor.— Dr. Auerbach reports (227:326, 1974) on the topical use of dibutylated cyclic adenosine monophosphate (cyclic AMP) in patients with psoriasis, the rationale being to elevate the reduced levels of skin cyclic AMP in these people. He observed either no improvement or worsening of lesions and suggests several possible reasons for lack of ...
openaire +3 more sources